Literature DB >> 10674673

Analysis of repeated hemoglobin measures in full-term, normal birth weight Kenyan children between birth and four years of age. III. The Asemobo Bay Cohort Project.

P D McElroy1, A A Lal, W A Hawley, P B Bloland, F O Kuile, A J Oloo, S D Harlow, X Lin, B L Nahlen.   

Abstract

Anemia is an important public health problem. During very early childhood numerous factors affect hemoglobin (Hb) concentration over time, making single cross-sectional measurements difficult to interpret when studying the natural history of anemia or evaluating anemia control strategies. We analyzed repeated Hb measures contributed by 942 Kenyan children between birth and 48 months of life using a mixed effects model, with a regression spline used to describe the population mean Hb profile, and random intercepts and slopes and first-order autoregressive correlation structure to accommodate the within-individual correlation among the repeated Hb measures. The approach facilitates the study of time-stationary and time-varying covariates that influence Hb in early life. The fitted mean Hb profile obtained from the analytic model is consistent with the observed mean Hb of the study population. Village of residence was associated with greatest difference in mean Hb at time of birth (16 versus 19 g/dL; P < 0.0001). Monthly weight-for-age was also associated with mean Hb after 3 months of age. This is the first description of an analysis strategy specifically for repeated Hb measures collected in a longitudinal field study in Africa. The strategy will facilitate improved study of time-varying covariates thought to influence pediatric anemia.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10674673     DOI: 10.4269/ajtmh.1999.61.932

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  37 in total

1.  Placental malaria diminishes development of antibody responses to Plasmodium falciparum epitopes in infants residing in an area of western Kenya where P. falciparum is endemic.

Authors:  Phillip Cullison Bonner; Zhiyong Zhou; Lisa B Mirel; John G Ayisi; Ya Ping Shi; Anna M van Eijk; Juliana A Otieno; Bernard L Nahlen; Richard W Steketee; Venkatachalam Udhayakumar
Journal:  Clin Diagn Lab Immunol       Date:  2005-03

2.  Functional haplotypes of Fc gamma (Fcγ) receptor (FcγRIIA and FcγRIIIB) predict risk to repeated episodes of severe malarial anemia and mortality in Kenyan children.

Authors:  Collins Ouma; Gregory C Davenport; Steven Garcia; Prakasha Kempaiah; Ateefa Chaudhary; Tom Were; Samuel B Anyona; Evans Raballah; Stephen N Konah; James B Hittner; John M Vulule; John M Ong'echa; Douglas J Perkins
Journal:  Hum Genet       Date:  2011-08-05       Impact factor: 4.132

3.  Strain-specific duffy binding protein antibodies correlate with protection against infection with homologous compared to heterologous plasmodium vivax strains in Papua New Guinean children.

Authors:  Jennifer L Cole-Tobian; Pascal Michon; Moses Biasor; Jack S Richards; James G Beeson; Ivo Mueller; Christopher L King
Journal:  Infect Immun       Date:  2009-06-29       Impact factor: 3.441

4.  A novel functional variant in the stem cell growth factor promoter protects against severe malarial anemia.

Authors:  Collins Ouma; Christopher C Keller; Gregory C Davenport; Tom Were; Stephen Konah; Michael F Otieno; James B Hittner; John M Vulule; Jeremy Martinson; John M Ong'echa; Robert E Ferrell; Douglas J Perkins
Journal:  Infect Immun       Date:  2009-11-02       Impact factor: 3.441

5.  Reduced systemic bicyclo-prostaglandin-E2 and cyclooxygenase-2 gene expression are associated with inefficient erythropoiesis and enhanced uptake of monocytic hemozoin in children with severe malarial anemia.

Authors:  Samuel B Anyona; Prakasha Kempaiah; Evans Raballah; Gregory C Davenport; Tom Were; Stephen N Konah; John M Vulule; James B Hittner; Charity W Gichuki; John M Ong'echa; Douglas J Perkins
Journal:  Am J Hematol       Date:  2012-06-23       Impact factor: 10.047

6.  Polymorphisms in genes of interleukin 12 and its receptors and their association with protection against severe malarial anaemia in children in western Kenya.

Authors:  Lyna Zhang; Donald Prather; Jodi Vanden Eng; Sara Crawford; Simon Kariuki; Feiko ter Kuile; Dianne Terlouw; Bernard Nahlen; Altaf A Lal; Laurence Slutsker; Venkatachalam Udhayakumar; Ya Ping Shi
Journal:  Malar J       Date:  2010-03-29       Impact factor: 2.979

7.  Intermittent preventive treatment in infants for the prevention of malaria in rural Western kenya: a randomized, double-blind placebo-controlled trial.

Authors:  Frank O Odhiambo; Mary J Hamel; John Williamson; Kim Lindblade; Feiko O ter Kuile; Elizabeth Peterson; Peter Otieno; Simon Kariuki; John Vulule; Laurence Slutsker; Robert D Newman
Journal:  PLoS One       Date:  2010-04-02       Impact factor: 3.240

8.  Polymorphic variability in the interleukin (IL)-1beta promoter conditions susceptibility to severe malarial anemia and functional changes in IL-1beta production.

Authors:  Collins Ouma; Gregory C Davenport; Gordon A Awandare; Christopher C Keller; Tom Were; Michael F Otieno; John M Vulule; Jeremy Martinson; John M Ong'echa; Robert E Ferrell; Douglas J Perkins
Journal:  J Infect Dis       Date:  2008-10-15       Impact factor: 5.226

9.  Polymorphisms in the Fc gamma receptor IIIA and Toll-like receptor 9 are associated with protection against severe malarial anemia and changes in circulating gamma interferon levels.

Authors:  Elly O Munde; Winnie A Okeyo; Samwel B Anyona; Evans Raballah; Stephen Konah; Wilson Okumu; Lilian Ogonda; John Vulule; Collins Ouma
Journal:  Infect Immun       Date:  2012-10-08       Impact factor: 3.441

10.  Can prenatal malaria exposure produce an immune tolerant phenotype? A prospective birth cohort study in Kenya.

Authors:  Indu Malhotra; Arlene Dent; Peter Mungai; Alex Wamachi; John H Ouma; David L Narum; Eric Muchiri; Daniel J Tisch; Christopher L King
Journal:  PLoS Med       Date:  2009-07-28       Impact factor: 11.069

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.